Yes, there are medications for dementia, though what’s available depends on the type of dementia and how far it has progressed. Some drugs help manage cognitive symptoms like memory loss and confusion. Newer treatments target the underlying disease process in Alzheimer’s. And a separate category of medications addresses behavioral symptoms like agitation, hallucinations, and sleep disturbances. No current medication cures any form of dementia, but several can meaningfully slow decline or improve quality of life.
Medications That Help With Memory and Thinking
The most widely prescribed dementia drugs are cholinesterase inhibitors. These work by boosting levels of a brain chemical involved in memory and learning that gradually drops as dementia progresses. Three are currently available: donepezil, rivastigmine, and galantamine. All three are used for mild to moderate Alzheimer’s disease, and rivastigmine is also approved for dementia related to Parkinson’s disease. Rivastigmine comes as both a pill and a skin patch, which can be easier to tolerate.
These medications don’t stop the disease from advancing. What they do is help the brain use its remaining chemical signals more efficiently, which can stabilize or temporarily improve memory, attention, and the ability to carry out daily tasks. The benefit varies from person to person. Some people notice a clear improvement, while others see a more subtle slowing of decline.
A fourth drug, memantine, works through a different mechanism. It regulates a signaling chemical called glutamate that, in excess, can damage brain cells. Memantine is typically used for moderate to severe Alzheimer’s and is sometimes combined with a cholinesterase inhibitor. Together, the two approaches address different aspects of the disease.
Common Side Effects of These Drugs
Cholinesterase inhibitors most commonly cause nausea, vomiting, diarrhea, and loss of appetite. These side effects are usually worst when starting the medication or increasing the dose, which is why doctors raise doses gradually over several weeks. Donepezil, for instance, typically starts at 5 mg daily for four to six weeks before moving to 10 mg.
A less common but more serious risk is a slowed heart rate. Research tracking older adults with dementia found that those taking cholinesterase inhibitors had roughly 69% higher rates of hospital visits for abnormally slow heart rhythms compared to those not taking the drugs. Fainting episodes were also more frequent. This risk is worth discussing if you or a family member already has a heart condition. Memantine tends to be better tolerated overall, with dizziness, headache, and constipation as the most reported issues.
Newer Treatments That Target Alzheimer’s Directly
A newer class of Alzheimer’s drugs takes a fundamentally different approach. Instead of managing symptoms, these medications aim to slow the disease itself by clearing amyloid plaques, the sticky protein clumps that build up in the brains of people with Alzheimer’s. Two are currently available: lecanemab (Leqembi) and donanemab (Kisunla), both approved by the FDA.
Lecanemab slowed the rate of cognitive decline by 27% over 18 months in a clinical trial of people with early-stage Alzheimer’s. Donanemab showed similar benefits in its own trials. Both are given as intravenous infusions, typically every two to four weeks in a clinic or infusion center. Donanemab starts at a lower dose for the first three infusions, then increases.
These drugs are only for people in the early stages of the disease: mild cognitive impairment or mild dementia. They require confirmation of amyloid buildup in the brain through a PET scan or spinal fluid test before treatment can begin. A 27% slowing of decline is meaningful but modest. In practical terms, it translates to several more months of independent functioning over the course of treatment. An earlier amyloid-targeting drug, aducanumab (Aduhelm), was discontinued by its manufacturer in 2024 and is no longer available.
The main safety concern with amyloid-clearing drugs is brain swelling or small brain bleeds, which show up on MRI scans. Most cases are mild and cause no symptoms, but regular brain imaging is required during treatment to monitor for this. People who carry two copies of a specific genetic variant (APOE4) face higher risk of these side effects.
Medications for Behavioral Symptoms
As dementia progresses, many people develop symptoms that go beyond memory loss: agitation, aggression, anxiety, depression, sleep disruption, and sometimes hallucinations or delusions. These behavioral changes are often more distressing for families than the cognitive decline itself, and they have their own set of treatment options.
Antipsychotic medications are sometimes used for severe agitation or hallucinations, but they carry significant risks in people with dementia. Guidelines recommend trying non-drug approaches first, such as adjusting the environment, establishing routines, or identifying triggers for distress. Antipsychotics should generally be reserved for situations where someone is at risk of harming themselves or others, or when hallucinations and delusions are causing serious distress. The lowest effective dose for the shortest possible time is the guiding principle.
Antidepressants, particularly certain types that boost serotonin activity, are sometimes prescribed for the depression and apathy that frequently accompany dementia. Trazodone, a sedating antidepressant, has shown effectiveness for behavioral symptoms in some forms of dementia, though it comes with a higher rate of side effects like drowsiness and dizziness.
Treatment Differs by Dementia Type
Not all dementia is Alzheimer’s, and the type matters when choosing medication.
Vascular dementia results from reduced blood flow to the brain, often after strokes or from chronic damage to small blood vessels. There are no drugs specifically approved for it. Treatment focuses on managing the underlying vascular risk factors: controlling blood pressure, managing cholesterol, and preventing further strokes. Cholinesterase inhibitors are sometimes tried, though the evidence for their benefit in vascular dementia is weaker than in Alzheimer’s.
Lewy body dementia requires especially careful medication choices. Cholinesterase inhibitors can help with the hallucinations and cognitive fluctuations that characterize this condition. For visual hallucinations that need additional treatment, only certain antipsychotics are considered safe. Quetiapine and clozapine are preferred because traditional antipsychotic medications like haloperidol can cause severe, potentially dangerous reactions in people with Lewy body dementia. Movement symptoms, which overlap with Parkinson’s disease, may be treated with carbidopa/levodopa, though mild symptoms are often left untreated to avoid adding side effects.
Frontotemporal dementia primarily affects personality, behavior, and language rather than memory, and it tends to strike at younger ages. No medications are approved specifically for it. Trazodone has shown benefit for the behavioral changes, including impulsivity and agitation. Interestingly, paroxetine, a common antidepressant, was not found effective for these symptoms in clinical trials. Some medications used for other dementias can actually worsen frontotemporal dementia symptoms, making accurate diagnosis essential before starting treatment.
What Medication Can and Cannot Do
The honest picture is that current medications offer real but limited help. Cholinesterase inhibitors and memantine can stabilize symptoms for months to a couple of years in many people, giving families valuable time. The newer amyloid-targeting drugs represent a shift toward treating the disease process itself, but they work only in early Alzheimer’s and slow rather than stop progression.
Medication is most effective as part of a broader approach. Physical exercise, cognitive engagement, social connection, proper nutrition, and well-managed sleep all contribute to maintaining function. For caregivers trying to manage behavioral symptoms, structured routines and environmental modifications often accomplish as much as any pill. The right medication strategy depends on the specific diagnosis, the stage of disease, other health conditions, and which symptoms are most affecting daily life.